Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of this study was to assess the commutability of three external quality assessment (EQA) materials for point‐of‐care (POC) glucose testing using two approaches, to identify suitable EQA materials to evaluate and monitor the quality of POC testing.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Commercial control materials (CCMs), pooled human serum samples (PHSs), and homemade human whole‐blood samples (HWBs) were measured along with 33 individual clinical samples using five POC instruments and a Hitachi 7600 analyzer. Data were analyzed by Deming regression analysis with a 95% prediction interval as described in Clinical and Laboratory Standards Institute (CLSI) EP30‐A, and by difference in bias analysis as described by the International Federation of Clinical Chemistry (IFCC) Working Group on Commutability.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Using the CLSI approach, HWBs, CCMs, and PHSs were commutable with five, one, and two instruments, respectively. With the IFCC approach, HWBs were commutable with two instruments, while CCMs and PHSs were largely inconclusive or non‐commutable on five instruments.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>HWBs were commutable on all instruments by the CLSI approach and may be a suitable EQA material for POC testing. Although some results differed between the IFCC and CLSI approaches, both indicated that HWBs were far superior to CCMs and PHSs in commutability.</p></section>

What problem does this paper attempt to address?

The paper aims to evaluate the interchangeability of three types of External Quality Assessment (EQA) materials in point-of-care testing (POCT) for blood glucose, to determine suitable EQA materials for assessing and monitoring the quality of POCT. Specifically, the researchers used two methods (Clinical and Laboratory Standards Institute CLSI method and International Federation of Clinical Chemistry IFCC method) to evaluate the interchangeability of commercial control materials (CCMs), pooled human serum samples (PHSs), and homemade whole blood samples (HWBs). ### Research Background Point-of-care testing (POCT) has become increasingly important in clinical laboratory medicine due to its portability and ease of operation. In particular, point-of-care blood glucose testing plays a crucial role in the treatment and management of diabetes. However, despite the stringent accuracy assessment standards proposed by many international organizations, the accuracy of point-of-care blood glucose testing remains unsatisfactory. This is mainly due to measurement differences between different point-of-care testing instruments and between these instruments and central laboratory analyzers. ### Research Objective The main objective of this study is to evaluate the interchangeability of three EQA materials (CCMs, PHSs, and HWBs) on five mainstream point-of-care blood glucose testing instruments and to assess them using both CLSI and IFCC methods to determine the most suitable EQA materials for assessing and monitoring the quality of point-of-care blood glucose testing. ### Research Methods 1. **Experimental Design**: The researchers used five mainstream brands of point-of-care blood glucose testing instruments and a laboratory analyzer (Hitachi 7600). 2. **Sample Preparation**: Including 33 individual clinical samples, three concentrations of commercial control materials (CCMs), pooled human serum samples (PHSs), and homemade whole blood samples (HWBs). 3. **Measurement Methods**: All samples were measured on the same day using the five point-of-care testing instruments and the Hitachi 7600 analyzer, with each sample measured three times. 4. **Data Analysis**: Deming regression analysis and bias difference analysis were used to evaluate interchangeability according to CLSI and IFCC methods, respectively. ### Main Results 1. **CLSI Method**: HWBs showed good interchangeability on all five instruments, while CCMs and PHSs showed limited interchangeability on some instruments. 2. **IFCC Method**: HWBs showed good interchangeability on two instruments, while CCMs and PHSs were uncertain or non-interchangeable on most instruments. ### Conclusion Compared to CCMs and PHSs, HWBs demonstrated better interchangeability characteristics in both evaluation methods, making them suitable as EQA materials for assessing and monitoring the analytical quality of point-of-care blood glucose testing. Additionally, the study recommends using the IFCC method for interchangeability evaluation when selecting EQA materials.

Commutability of external quality assessment materials for point‐of‐care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches

Commutability Assessment of Candidate External Quality Assessment Materials for Aminotransferase Activity Measurements Based on Different Approaches in China

Exploration of suitable external quality assessment materials for serum C-peptide measurement

New concept for control material in glucose point-of-care-testing for external quality assessment schemes

Comparability of thyroid-stimulating hormone immunoassays using fresh frozen human sera and external quality assessment data

Commutability evaluation of candidate reference materials and ERM‐DA470k/IFCC for immunoglobulin M using two international approaches

Evaluating the Commutability of Reference Materials for α-Fetoprotein: Accurate Value Assignment With Multiple Systems and Trueness Verification

The real world of blood glucose point-of-care testing (POCT) system running in China teaching hospital

Comparison of POCT glucose meters and analysis of the interference factor

Analytic performance evaluation of five kinds of point-of-care testing blood glucose meters

Sharing reference intervals and monitoring patients across laboratories – findings from a likely commutable external quality assurance program

Evaluation of blood lead measurements by the 6-year external quality assessment program in China

Assessment of patient based real‐time quality control on comparative assays for common clinical analytes

Analytical Performance Evaluation of the GreenCare A1c and Cera-Stat HbA1c Point-Of-Care Testing Assays

External quality assessment performance in ten countries: an IFCC global laboratory quality project

Differences in the System Accuracy Acceptability of Four Types of Blood Glucose Monitoring Systems Against Five Different Standards

Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems

Evaluation of the Comparability of Wantai Wan200+ Instrument with Routine Laboratory Assays for 21 Different Analytes

Analysis of the comparability of the results of 26 serum biochemical indicators in two different biochemical analysis systems

Management of Point-of-care Testing Glucose Monitoring Program in Hospital in the JCI Accreditation

Navigation between EQA and sustainability